Clozapine's superior efficacy in treatment-resistant schizophrenia is attributed to which receptor pharmacology profile distinguishing it from other second-generation antipsychotics?

• A Near-complete and persistent D2 receptor blockade (>95% occupancy) in the limbic system
• B Selective D3 receptor partial agonism preventing dopamine supersensitivity
• C Inverse agonism at D2 receptors combined with full blockade of muscarinic M1 receptors
• D High D4/D2 ratio blockade, 5-HT2A antagonism, and rapid dissociation from D2 ('fast-off' kinetics) resulting in minimal EPS ✓

Explanation

Clozapine has several distinguishing features: (1) high relative D4:D2 affinity (D4 blockade may mediate antipsychotic efficacy in treatment-resistant patients), (2) potent 5-HT2A antagonism (which enhances prefrontal dopaminergic transmission, improving negative symptoms and cognitive function), and (3) 'fast-off' kinetics from D2 receptors (low receptor residence time), explaining virtual absence of EPS despite clinical antipsychotic efficacy. D2 occupancy with clozapine is typically only 20–60%, in contrast to haloperidol's 80–90%, yet efficacy is superior. The H1, M1, M4, and α1 blockade contribute to its side-effect burden (sedation, hypersalivation, weight gain).

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.